Researchers claim basic conclusions still sound.
Standardized scale to harmonize results from different imaging strategies.
Primates tolerate treatment with bispecific antibodies that smuggle anti-BACE1 across the blood-brain barrier.
Vancouver Frontotemporal Dementia Conference Shows Awakening Field First Data from GENFI1: Brain’s Insula Region Shrinks A Decade Before FTD German Network of 700 FTLD Patients Presents Baseline Data Meet the Artful Leftie: NIH Jump-Starts U.S.-Canadian ...
Scientific advances fire up researchers at FTD meeting in a dreary Vancouver.
Compound clears Phase 1 hurdle.
A drug that inhibits the sodium/potassium pump rescues a mouse model of the disease.
A protease previously linked to hyperphosphorylation of tau is now found to cleave the protein. The enzyme worsens tau pathology in transgenic mice.
A small Aβ fragment produced in healthy brains binds acetylcholine receptors and enhances synaptic plasticity and learning, while blocking the toxic effects of Aβ42.
Compounds derived from cocoa beans boost blood volume to part of the brain, and may counteract age-related decline in memory.
A broad genetic analysis suggests that mutations in a microtubule subunit enhance the risk for ALS.
A protein from the Borna disease virus rescues mitochondria and keeps stressed neurons viable, suggesting a new neuroprotective strategy.
MRI in mice could help explain disconnections in neural circuitry that precede amyloid plaques.
The severity of ALS correlates with how badly mutations destabilize superoxide dismutase 1, and promote its aggregation, according to a new study.
By beaming red light at a blood sample and measuring the scattered photons, scientists claim to identify people with Alzheimer’s disease.